{{Rsnum
|rsid=3755724
|Gene=SYN2
|Chromosome=3
|position=12159406
|Orientation=plus
|GMAF=0.3682
|Gene_s=SYN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 41.6 | 14.2
| HCB | 14.6 | 45.3 | 40.1
| JPT | 20.4 | 42.5 | 37.2
| YRI | 91.8 | 7.5 | 0.7
| ASW | 73.7 | 22.8 | 3.5
| CHB | 14.6 | 45.3 | 40.1
| CHD | 11.9 | 43.1 | 45.0
| GIH | 21.8 | 49.5 | 28.7
| LWK | 66.4 | 30.0 | 3.6
| MEX | 55.2 | 37.9 | 6.9
| MKK | 51.9 | 39.7 | 8.3
| TSI | 36.3 | 53.9 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22796276
|Title=The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations
}}

{{PMID Auto
|PMID=17766091
|Title=Association of synapsin 2 with schizophrenia in families of Northern European ancestry.
|OA=1
}}

{{PMID Auto
|PMID=19048177
|Title=Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population.
}}

{{PMID Auto
|PMID=23229788
|Title=Assessment of the correlation between TIMP4 SNPs and schizophrenia and             autism spectrum disorders
}}

{{PMID Auto
|PMID=24903383
|Title=TIMP-3 -1296 T&gt;C and TIMP-4 -55 T&gt;C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}